The Center for International Blood and Marrow Transplant Research (CIBMTR) Launches Study of COVID-19 Vaccine Immunogenicity in Patients With Hematological Malignancies Who Have Received Cellular Therapy
MINNEAPOLIS–(BUSINESS WIRE)–The CIBMTR® (Center for International Blood and Marrow Transplant Research®) announces the launch of a large observational study, done in collaboration with the Blood and Marrow Transplant Clinical Trials…
Read more



